APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-protein Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bio-protein Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchBio-protein Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-protein Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Bio-protein Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-protein Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-protein Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Bio-protein Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bio-protein Drug include Abbott Laboratories, Sanofi, Johnson & Johnson, Novartis AG, Merck, Roche, GlaxoSmithKline, Bayer AG and Amgen Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bio-protein Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bio-protein Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bio-protein Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bio-protein Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Bio-protein Drug Segment by Company

Abbott Laboratories

Sanofi

Johnson & Johnson

Novartis AG

Merck

Roche

GlaxoSmithKline

Bayer AG

Amgen Inc.

Reliance Life Science Pvt. Ltd.

ProBioGen AG

Panacea Biotec

Fresenius kabi

Eli Lilly and Company

Dr. Reddy’s Laboratories

Biocon Ltd.

Bio-protein Drug Segment by Type

Therapeutic Proteins

Vaccines

Monoclonal Antibodies

Bio-protein Drug Segment by Application

CROs

Academics

Pharma and Biotech Companies

Bio-protein Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-protein Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-protein Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-protein Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bio-protein Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bio-protein Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bio-protein Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bio-protein Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bio-protein Drug Industry Trends Table 2. Bio-protein Drug Industry Drivers Table 3. Bio-protein Drug Industry Opportunities and Challenges Table 4. Bio-protein Drug Industry Restraints Table 5. Global Bio-protein Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bio-protein Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bio-protein Drug Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Bio-protein Drug Sales Market Share by Manufacturers Table 9. Global Bio-protein Drug Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Bio-protein Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bio-protein Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bio-protein Drug Manufacturers, Product Type & Application Table 13. Global Bio-protein Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bio-protein Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Therapeutic Proteins Table 17. Major Manufacturers of Vaccines Table 18. Major Manufacturers of Monoclonal Antibodies Table 19. Global Bio-protein Drug Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Bio-protein Drug Sales by Type (2021-2026) & (W Tons) Table 21. Global Bio-protein Drug Sales by Type (2027-2032) & (W Tons) Table 22. Global Bio-protein Drug Sales Market Share by Type (2021-2026) Table 23. Global Bio-protein Drug Sales Market Share by Type (2027-2032) Table 24. Global Bio-protein Drug Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Bio-protein Drug Revenue by Type (2021-2026) & (W Tons) Table 26. Global Bio-protein Drug Revenue by Type (2027-2032) & (W Tons) Table 27. Global Bio-protein Drug Revenue Market Share by Type (2021-2026) Table 28. Global Bio-protein Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of CROs Table 30. Major Manufacturers of Academics Table 31. Major Manufacturers of Pharma and Biotech Companies Table 32. Global Bio-protein Drug Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Bio-protein Drug Sales by Application (2021-2026) & (W Tons) Table 34. Global Bio-protein Drug Sales by Application (2027-2032) & (W Tons) Table 35. Global Bio-protein Drug Sales Market Share by Application (2021-2026) Table 36. Global Bio-protein Drug Sales Market Share by Application (2027-2032) Table 37. Global Bio-protein Drug Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 38. Global Bio-protein Drug Revenue by Application (2021-2026) & (W Tons) Table 39. Global Bio-protein Drug Revenue by Application (2027-2032) & (W Tons) Table 40. Global Bio-protein Drug Revenue Market Share by Application (2021-2026) Table 41. Global Bio-protein Drug Revenue Market Share by Application (2027-2032) Table 42. Global Bio-protein Drug Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Bio-protein Drug Sales by Region (2021-2026) & (W Tons) Table 44. Global Bio-protein Drug Sales Market Share by Region (2021-2026) Table 45. Global Bio-protein Drug Sales Forecasted by Region (2027-2032) & (W Tons) Table 46. Global Bio-protein Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 48. North America Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 49. North America Bio-protein Drug Sales by Country (2027-2032) & (W Tons) Table 50. Europe Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 51. Europe Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 52. Europe Bio-protein Drug Sales by Country (2027-2032) & (W Tons) Table 53. Asia Pacific Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 54. Asia Pacific Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 55. Asia Pacific Bio-protein Drug Sales by Country (2027-2032) & (W Tons) Table 56. South America, Middle East and Africa Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. South America, Middle East and Africa Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 58. South America, Middle East and Africa Bio-protein Drug Sales by Country (2027-2032) & (W Tons) Table 59. Global Bio-protein Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Bio-protein Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Bio-protein Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Bio-protein Drug Revenue Market Share by Region (2021-2026) Table 63. Global Bio-protein Drug Revenue Market Share by Region (2027-2032) Table 64. Abbott Laboratories Company Information Table 65. Abbott Laboratories Business Overview Table 66. Abbott Laboratories Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Laboratories Bio-protein Drug Product Portfolio Table 68. Abbott Laboratories Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Bio-protein Drug Product Portfolio Table 73. Sanofi Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Bio-protein Drug Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Novartis AG Company Information Table 80. Novartis AG Business Overview Table 81. Novartis AG Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis AG Bio-protein Drug Product Portfolio Table 83. Novartis AG Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merck Bio-protein Drug Product Portfolio Table 88. Merck Recent Development Table 89. Roche Company Information Table 90. Roche Business Overview Table 91. Roche Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Roche Bio-protein Drug Product Portfolio Table 93. Roche Recent Development Table 94. GlaxoSmithKline Company Information Table 95. GlaxoSmithKline Business Overview Table 96. GlaxoSmithKline Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. GlaxoSmithKline Bio-protein Drug Product Portfolio Table 98. GlaxoSmithKline Recent Development Table 99. Bayer AG Company Information Table 100. Bayer AG Business Overview Table 101. Bayer AG Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bayer AG Bio-protein Drug Product Portfolio Table 103. Bayer AG Recent Development Table 104. Amgen Inc. Company Information Table 105. Amgen Inc. Business Overview Table 106. Amgen Inc. Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Amgen Inc. Bio-protein Drug Product Portfolio Table 108. Amgen Inc. Recent Development Table 109. Reliance Life Science Pvt. Ltd. Company Information Table 110. Reliance Life Science Pvt. Ltd. Business Overview Table 111. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio Table 113. Reliance Life Science Pvt. Ltd. Recent Development Table 114. ProBioGen AG Company Information Table 115. ProBioGen AG Business Overview Table 116. ProBioGen AG Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. ProBioGen AG Bio-protein Drug Product Portfolio Table 118. ProBioGen AG Recent Development Table 119. Panacea Biotec Company Information Table 120. Panacea Biotec Business Overview Table 121. Panacea Biotec Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Panacea Biotec Bio-protein Drug Product Portfolio Table 123. Panacea Biotec Recent Development Table 124. Fresenius kabi Company Information Table 125. Fresenius kabi Business Overview Table 126. Fresenius kabi Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Fresenius kabi Bio-protein Drug Product Portfolio Table 128. Fresenius kabi Recent Development Table 129. Eli Lilly and Company Company Information Table 130. Eli Lilly and Company Business Overview Table 131. Eli Lilly and Company Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Eli Lilly and Company Bio-protein Drug Product Portfolio Table 133. Eli Lilly and Company Recent Development Table 134. Dr. Reddy’s Laboratories Company Information Table 135. Dr. Reddy’s Laboratories Business Overview Table 136. Dr. Reddy’s Laboratories Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio Table 138. Dr. Reddy’s Laboratories Recent Development Table 139. Biocon Ltd. Company Information Table 140. Biocon Ltd. Business Overview Table 141. Biocon Ltd. Bio-protein Drug Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Biocon Ltd. Bio-protein Drug Product Portfolio Table 143. Biocon Ltd. Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Bio-protein Drug Distributors List Table 147. Bio-protein Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Bio-protein Drug Product Image Figure 2. Global Bio-protein Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-protein Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio-protein Drug Sales (2021-2032) & (W Tons) Figure 5. Global Bio-protein Drug Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Bio-protein Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Therapeutic Proteins Image Figure 9. Vaccines Image Figure 10. Monoclonal Antibodies Image Figure 11. Global Bio-protein Drug Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Bio-protein Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Bio-protein Drug Sales Market Share by Type (2021-2032) Figure 14. Global Bio-protein Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Bio-protein Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Bio-protein Drug Revenue Market Share by Type (2021-2032) Figure 17. CROs Image Figure 18. Academics Image Figure 19. Pharma and Biotech Companies Image Figure 20. Global Bio-protein Drug Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Bio-protein Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Bio-protein Drug Sales Market Share by Application (2021-2032) Figure 23. Global Bio-protein Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Bio-protein Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Bio-protein Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. North America Bio-protein Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Canada Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Mexico Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Europe Bio-protein Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. France Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. U.K. Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Italy Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Netherlands Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Asia Pacific Bio-protein Drug Sales Market Share by Country (2021-2032) Figure 40. China Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Japan Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. South Korea Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Southeast Asia Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. India Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Australia Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South America, Middle East and Africa Bio-protein Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South Africa Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Saudi Arabia Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Turkey Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Argentina Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. UAE Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Egypt Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Chile Bio-protein Drug Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Global Bio-protein Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Bio-protein Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Bio-protein Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Bio-protein Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Bio-protein Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Bio-protein Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Bio-protein Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Bio-protein Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Proteins
  • Vaccines
  • Monoclonal Antibodies
Applications
  • CROs
  • Academics
  • Pharma and Biotech Companies
Companies covered
  • Abbott Laboratories
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Merck
  • Roche
  • GlaxoSmithKline
  • Bayer AG
  • Amgen Inc.
  • Reliance Life Science Pvt. Ltd.
  • ProBioGen AG
  • Panacea Biotec
  • Fresenius kabi
  • Eli Lilly and Company
  • Dr. Reddy’s Laboratories
  • Biocon Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bio-protein Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bio-protein Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bio-protein Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bio-protein Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bio-protein Drug Market Dynamics
  1. 2.1 Bio-protein Drug Industry Trends
  2. 2.2 Bio-protein Drug Industry Drivers
  3. 2.3 Bio-protein Drug Industry Opportunities and Challenges
  4. 2.4 Bio-protein Drug Industry Restraints
3 Bio-protein Drug Market by Manufacturers
  1. 3.1 Global Bio-protein Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bio-protein Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bio-protein Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bio-protein Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bio-protein Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bio-protein Drug Manufacturers, Product Type & Application
  7. 3.7 Global Bio-protein Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bio-protein Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bio-protein Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bio-protein Drug Tier 1, Tier 2, and Tier 3
4 Bio-protein Drug Market by Type
  1. 4.1 Bio-protein Drug Type Introduction
  2. 4.1.1 Therapeutic Proteins
  3. 4.1.2 Vaccines
  4. 4.1.3 Monoclonal Antibodies
  5. 4.2 Global Bio-protein Drug Sales by Type
  6. 4.2.1 Global Bio-protein Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bio-protein Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Bio-protein Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Bio-protein Drug Revenue by Type
  10. 4.3.1 Global Bio-protein Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bio-protein Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Bio-protein Drug Revenue Market Share by Type (2021-2032)
5 Bio-protein Drug Market by Application
  1. 5.1 Bio-protein Drug Application Introduction
  2. 5.1.1 CROs
  3. 5.1.2 Academics
  4. 5.1.3 Pharma and Biotech Companies
  5. 5.2 Global Bio-protein Drug Sales by Application
  6. 5.2.1 Global Bio-protein Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bio-protein Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Bio-protein Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bio-protein Drug Revenue by Application
  10. 5.3.1 Global Bio-protein Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bio-protein Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Bio-protein Drug Revenue Market Share by Application (2021-2032)
6 Global Bio-protein Drug Sales by Region
  1. 6.1 Global Bio-protein Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bio-protein Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Bio-protein Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Bio-protein Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bio-protein Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bio-protein Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bio-protein Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bio-protein Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bio-protein Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bio-protein Drug Revenue by Region
  1. 7.1 Global Bio-protein Drug Revenue by Region
  2. 7.1.1 Global Bio-protein Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bio-protein Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Bio-protein Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Bio-protein Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bio-protein Drug Revenue (2021-2032)
  8. 7.2.2 North America Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bio-protein Drug Revenue (2021-2032)
  11. 7.3.2 Europe Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bio-protein Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bio-protein Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bio-protein Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Bio-protein Drug Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Bio-protein Drug Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Bio-protein Drug Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis AG
  20. 8.4.1 Novartis AG Company Information
  21. 8.4.2 Novartis AG Business Overview
  22. 8.4.3 Novartis AG Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis AG Bio-protein Drug Product Portfolio
  24. 8.4.5 Novartis AG Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Bio-protein Drug Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche Bio-protein Drug Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Bio-protein Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer AG
  44. 8.8.1 Bayer AG Company Information
  45. 8.8.2 Bayer AG Business Overview
  46. 8.8.3 Bayer AG Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer AG Bio-protein Drug Product Portfolio
  48. 8.8.5 Bayer AG Recent Developments
  49. 8.9 Amgen Inc.
  50. 8.9.1 Amgen Inc. Company Information
  51. 8.9.2 Amgen Inc. Business Overview
  52. 8.9.3 Amgen Inc. Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Amgen Inc. Bio-protein Drug Product Portfolio
  54. 8.9.5 Amgen Inc. Recent Developments
  55. 8.10 Reliance Life Science Pvt. Ltd.
  56. 8.10.1 Reliance Life Science Pvt. Ltd. Company Information
  57. 8.10.2 Reliance Life Science Pvt. Ltd. Business Overview
  58. 8.10.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio
  60. 8.10.5 Reliance Life Science Pvt. Ltd. Recent Developments
  61. 8.11 ProBioGen AG
  62. 8.11.1 ProBioGen AG Company Information
  63. 8.11.2 ProBioGen AG Business Overview
  64. 8.11.3 ProBioGen AG Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ProBioGen AG Bio-protein Drug Product Portfolio
  66. 8.11.5 ProBioGen AG Recent Developments
  67. 8.12 Panacea Biotec
  68. 8.12.1 Panacea Biotec Company Information
  69. 8.12.2 Panacea Biotec Business Overview
  70. 8.12.3 Panacea Biotec Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Panacea Biotec Bio-protein Drug Product Portfolio
  72. 8.12.5 Panacea Biotec Recent Developments
  73. 8.13 Fresenius kabi
  74. 8.13.1 Fresenius kabi Company Information
  75. 8.13.2 Fresenius kabi Business Overview
  76. 8.13.3 Fresenius kabi Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Fresenius kabi Bio-protein Drug Product Portfolio
  78. 8.13.5 Fresenius kabi Recent Developments
  79. 8.14 Eli Lilly and Company
  80. 8.14.1 Eli Lilly and Company Company Information
  81. 8.14.2 Eli Lilly and Company Business Overview
  82. 8.14.3 Eli Lilly and Company Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eli Lilly and Company Bio-protein Drug Product Portfolio
  84. 8.14.5 Eli Lilly and Company Recent Developments
  85. 8.15 Dr. Reddy’s Laboratories
  86. 8.15.1 Dr. Reddy’s Laboratories Company Information
  87. 8.15.2 Dr. Reddy’s Laboratories Business Overview
  88. 8.15.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio
  90. 8.15.5 Dr. Reddy’s Laboratories Recent Developments
  91. 8.16 Biocon Ltd.
  92. 8.16.1 Biocon Ltd. Company Information
  93. 8.16.2 Biocon Ltd. Business Overview
  94. 8.16.3 Biocon Ltd. Bio-protein Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Biocon Ltd. Bio-protein Drug Product Portfolio
  96. 8.16.5 Biocon Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bio-protein Drug Value Chain Analysis
  2. 9.1.1 Bio-protein Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bio-protein Drug Production Mode & Process
  6. 9.2 Bio-protein Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bio-protein Drug Distributors
  9. 9.2.3 Bio-protein Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst